首页 | 本学科首页   官方微博 | 高级检索  
检索        

不同剂量多西紫杉醇方案治疗老年晚期非小细胞肺癌
引用本文:张明军,陈振东,孙彤,黄忠连,陈磊,杨扬.不同剂量多西紫杉醇方案治疗老年晚期非小细胞肺癌[J].安徽医学,2009,30(8):905-907.
作者姓名:张明军  陈振东  孙彤  黄忠连  陈磊  杨扬
作者单位:安徽医科大学第二附属医院肿瘤科,合肥,230601;安徽医科大学第二附属医院肿瘤科,合肥,230601;安徽医科大学第二附属医院肿瘤科,合肥,230601;安徽医科大学第二附属医院肿瘤科,合肥,230601;安徽医科大学第二附属医院肿瘤科,合肥,230601;安徽医科大学第二附属医院肿瘤科,合肥,230601
摘    要:目的探讨多西紫杉醇周方案和三周方案治疗老年人非小细胞肺癌的临床疗效与不良反应。方法回顾性分析安徽医科大学第一附属医院2005年10月至2008年12月收治的73例用多西紫杉醇治疗的老年晚期非小细胞肺癌患者的临床资料。结果周方案治疗43例,有效率37.2%(16/43),三周方案治疗30例,有效率33.3%(12/30),不良反应主要有恶心呕吐、疲劳、中性粒细胞减少。结论多西紫杉醇周方案治疗老年人非小细胞肺癌疗效较好,不良反应较三周方案轻,患者易耐受。

关 键 词:多西紫杉醇  老年人  肺癌

Clinical research on different docetaxel schedules in the treatment of elderly patients with advanced non-smal cell lung canccer
Zhang Mingjun,Chen Zhendong,Sun Tong,et al.Clinical research on different docetaxel schedules in the treatment of elderly patients with advanced non-smal cell lung canccer[J].Anhui Medical Journal,2009,30(8):905-907.
Authors:Zhang Mingjun  Chen Zhendong  Sun Tong  
Institution:Zhang Mingjun,Chen Zhendong,Sun Tong,et al Department of Oncology,the Second Affiliated Hospital of Anhui Medical University,Hefei 230601
Abstract:Objective To evaluate the efficacy and toxicity of docetaxel administered weekly or 3-weekly to elderly patients with advanced non-smal cell lung cancer(NSCLC).Methods The clinical data of 73 elderly patients with advanced non-smal cell lung cancer admitted from October 2005 to December 2008 to the First Affiliated Hospital of Anhui Medical University were analyzed retrospectively.Results The overall response rate(RR) were 37.2% and 33.3% for the patients treated with weekly or 3-weekly docetaxel regimen re...
Keywords:Docetaxel  Elderly patients  Lung cancer  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号